ISB
Blood-Based Omics Signatures Reflect 'Biological' BMI, Metabolic Health
Features found in the blood offered a more refined look at obesity and related conditions, shifting more readily than body mass index in response to lifestyle changes.
The method, which uses a metabolic marker called hexokinase-2, could be developed to predict cancer patient prognosis and determine progression-free survival.
Merck, ISB Collaborating on COVID-19 Drug, Vaccine Target Discovery
Backed by BARDA, Merck and Institute for Systems Biology are studying multiomic
Researchers' picks range from emerging tools like deep learning to fundamental issues like false discovery rates and infrastructure for mass spec data sharing.
Highlights included mass spec-focused developments like data-independent acquisition and ion mobility along with platforms including Thermo Fisher's Q Exactive.
Apr 25, 2019
Arivale Shuts Down Personalized Wellness Business
Apr 2, 2018
New TCGA Papers Shed Light on Cancer Development
Mar 1, 2017
Jan 7, 2016
Sep 10, 2013
Paired Ends: Lee Hood
Premium
Sep 6, 2013
Aug 14, 2013
People in the News: Leroy Hood
Premium
Aug 13, 2013
Paired Ends: Leroy Hood
Premium
Jul 23, 2013
May 14, 2013